Fiona Phillips and her husband Martin Frizell has detailed the worrying time they feared their sons Nathaniel, 26, and ...

Indianapolis: Eli Lilly and Company has received approval from the U.S. Food and Drug Administration (FDA) for a label update ...

A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric symptoms and potentially slowing cognitive decline in Parkinson's disease ...

Researchers have identified sequential diagnostic patterns that may enhance early detection and improve strategies for disease prevention. Researchers at UCLA Health have uncovered four distinct ...

Boston police have located 84-year-old Antonio Toribio of Roxbury who had been reported missing Monday. Toribio was last seen ...

Dementia remains a leading cause of disability and dependency among older adults, affecting an estimated 55 million people globally, according to the World Health Organization.

Using brain gene expression maps from the Allen Human Brain Atlas, the researchers tested the degree to which Alzheimer’s risk genes explain the patterns of both actual and residual tau. This allowed ...

A new study reveals that our organs age at different speeds, and those differences can predict future disease risk and even ...

The kickoff for the Waco 2025 Walk to End Alzheimer’s Disease is Tuesday night, and you’re invited! The official launch and ...

Alzheimer’s disease continues to rise as one of the most pressing health challenges facing aging populations today. It ...

Researchers from DZNE, Ludwig-Maximilians-Universität München (LMU), and Technical University of Munich (TUM) have found that ...

The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...